Toll like receptor 2 mediates bleomycin-induced acute lung injury, inflammation and fibrosis in mice

Yaoxue Xuebao

Volumn 45, Issue 8, 2010, Pages 976-986

  Liu, Han Zhi ^a   Yang, Hong Zhen ^a   Mi, Su ^a   Cui, Bing ^a   Hua, Fang ^a   Hu, Zhuo Wei ^a  

^a INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

Acute lung injury; Bleomycin; Dendritic cell; Fibrosis; Pulmonary inflammation; TLR2

Indexed keywords

BLEOMYCIN; INTERLEUKIN 17; INTERLEUKIN 23; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; TOLL LIKE RECEPTOR 2;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL MATURATION; CYTOKINE RELEASE; DENDRITIC CELL; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; IMMUNOSUPPRESSIVE TREATMENT; IN VIVO STUDY; INFLAMMATORY CELL; LUNG FIBROSIS; LUNG INJURY; LUNG LAVAGE; MOUSE; NONHUMAN; PNEUMONIA; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SURVIVAL; TH1 CELL; TH17 CELL; TH2 CELL; WESTERN BLOTTING;

ACUTE LUNG INJURY; ANIMALS; BLEOMYCIN; BRONCHOALVEOLAR LAVAGE FLUID; CELLS, CULTURED; CYTOKINES; DENDRITIC CELLS; INFLAMMATION; INTERLEUKIN-17; INTERLEUKIN-23; INTERLEUKIN-6; LUNG; MALE; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED C57BL; PULMONARY FIBROSIS; T-LYMPHOCYTES, REGULATORY; TH1 CELLS; TH2 CELLS; TOLL-LIKE RECEPTOR 2;

EID: 77957914360     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Wynn TA. Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases [J]. J Clin Invest, 2007, 117: 524-529.
2. Tsushima K, King LS, Aggarwal NR, et al. Acute lung injury review [J]. Intern Med, 2009, 48: 621-630.
3. Davies HR, Richeldi L. Idiopathic pulmonary fibrosis: current and future treatment options [J]. Am J Respir Med, 2002, 1: 211-224. (Pubitemid 37038940)
4. Cuzzocrea S, Ronchetti S, Genovese T, et al. Genetic and pharmacological inhibition of GITR-GITRL interaction reduces chronic lung injury induced by bleomycin instillation [J]. FASEB J, 2007, 21: 117-129. (Pubitemid 46052551)
5. Matute-Bello G, Frevert CW, Martin TR. Animal models of acute lung injury [J]. Am J Physiol Lung Cell Mol Physiol, 2008, 295: L379-399.
6. Raymond T, Schaller M, Hogaboam CM, et al. Toll-like receptors, Notch ligands, and cytokines drive the chronicity of lung inflammation [J]. Proc Am Thorac Soc, 2007, 4: 635-641.
7. Hou B, Reizis B, DeFranco AL. Toll-like receptors activate innate and adaptive immunity by using dendritic cell-intrinsic and -extrinsic mechanisms [J]. Immunity, 2008, 29: 272-282.
8. Bianchi ME. DAMPs, PAMPs and alarmins: all we need to know about danger [J]. J Leukocyte Biol, 2007, 81: 1-5.
9. Zhang Q, Raoof M, Chen Y, et al. Circulating mitochondrial DAMPs cause inflammatory responses to injury [J]. Nature, 2010, 464: 104-107.
10. Razonable RR, Henault M, Paya CV. Stimulation of toll-like receptor 2 with bleomycin results in cellular activation and secretion of pro-inflammatory cytokines and chemokines [J]. Toxicol Appl Pharmacol, 2006, 210: 181-189.
11. Daubeuf B, Mathison J, Spiller S, et al. TLR4/MD-2 monoclonal antibody therapy affords protection in experimental models of septic shock [J]. J Immunol, 2007, 179: 6107-6114.
12. Meng G, Rutz M, Schiemann M, et al. Antagonistic antibody prevents toll-like receptor 2-driven lethal shock-like syndromes [J]. J Clin Invest, 2004, 113: 1473-1481.
13. Squaiella CC, Ananias RZ, Mussalem JS, et al. In vivo and in vitro effect of killed Propionibacterium acnes and its purified soluble polysaccharide on mouse bone marrow stem cells and dendritic cell differentiation [J]. Immunobiology, 2006, 211: 105-116.
14. ten Hoeve J, de Jesus Ibarra-Sanchez M, Fu Y, et al. Identification of a nuclear Stat1 protein tyrosine phosphatase [J]. Mol Cell Biol, 2002, 22: 5662-5668.
15. Casey J, Kaplan J, Atochina-Vasserman EN, et al. Alveolar surfactant protein D content modulates bleomycin-induced lung injury [J]. Am J Respir Crit Care Med, 2005, 172: 869-877.
16. Knapp S, Florquin S, Golenbock DT, et al. Pulmonary lipopolysaccharide (LPS)-binding protein inhibits the LPS-induced lung inflammation in vivo [J]. J Immunol, 2006, 176: 3189-3195.
17. Tanino Y, Makita H, Miyamoto K, et al. Role of macrophage migration inhibitory factor in bleomycin-induced lung injury and fibrosis in mice [J]. Am J Physiol Lung Cell Mol Physiol, 2002, 283: L156-162.
18. Reddy GK, Enwemeka CS. A simplified method for the analysis of hydroxyproline in biological issues [J]. Clin Biochem, 1996, 29: 225-229.
19. Dillon S, Agrawal A, Van Dyke T, et al. A Toll-like receptor 2 ligand stimulates Th2 responses in vivo, via induction of extracellular signal-regulated kinase mitogen-activated protein kinase and c-Fos in dendritic cells [J]. J Immunol, 2004, 172: 4733-4743.
20. Dobrovolskaia MA, Medvedev AE, Thomas KE, et al. Induction of in vitro reprogramming by Toll-like receptor (TLR)2 and TLR4 agonists in murine macrophages: effects of TLR "homotolerance" versus "heterotolerance" on NF-kappa B signaling pathway components [J]. J Immunol, 2003, 170: 508-519.
21. Huaux F, Liu T, McGarry B, et al. Eosinophils and T lymphocytes possess distinct roles in bleomycin-induced lung injury and fibrosis [J]. J Immunol, 2003, 171: 5470-5481.
22. Yang HZ, Cui B, Liu HZ, et al. Targeting TLR2 attenuates pulmonary inflammation and fibrosis by reversion of suppressive immune microenvironment [J]. J Immunol, 2009, 182: 692-702.
23. Wenink MH, Santegoets KC, Broen JC, et al. TLR2 promotes Th2/Th17 responses via TLR4 and TLR7/8 by abrogating the type I IFN amplification loop [J]. J Immunol, 2009, 183: 6960-6970.
24. Amati L, Pepe M, Passeri ME, et al. Toll-like receptor signaling mechanisms involved in dendritic cell activation: potential therapeutic control of T cell polarization [J]. Curr Pharm Des, 2006, 12: 4247-4254.
25. Imanishi T, Hara H, Suzuki S, et al. Cutting edge: TLR2 directly triggers Th1 effector functions [J]. J Immunol, 2007, 178: 6715-6719.
26. Yang D, Chen Q, Su SB, et al. Eosinophil-derived neurotoxin acts as an alarmin to activate the TLR2-MyD88 signal pathway in dendritic cells and enhances Th2 immune responses [J]. J Exp Med, 2008, 205: 79-90.
27. Schauber J, Dorschner RA, Coda AB, et al. Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D-dependent mechanism [J]. J Clin Invest, 2007, 117: 803-811.
28. McKenzie BS, Kastelein RA, Cua DJ. Understanding the IL-23-IL-17 immune pathway [J]. Trends Immunol, 2006, 27: 17-23.
29. Filep JG, El Kebir D. Neutrophil apoptosis: a target for enhancing the resolution of inflammation [J]. J Cell Biochem, 2009, 108: 1039-1046.
30. Knauer J, Siegemund S, Muller U, et al. Borrelia burgdorferi potently activates bone marrow-derived conventional dendritic cells for production of IL-23 required for IL-17 release by T cells [J]. FEMS Immunol Med Microbiol. 2007, 49: 353-363.
31. Umemura M, Yahagi A, Hamada S, et al. IL-17-mediated regulation of innate and acquired immune response against pulmonary Mycobacterium bovis Bacille Calmette-Guerin infection [J]. J Immunol, 2007, 178: 3786-3796.
32. Shuto T, Furuta T, Oba M, et al. Promoter hypomethylation of Toll-like receptor-2 gene is associated with increased proinflammatory response toward bacterial peptidoglycan in cystic fibrosis bronchial epithelial cells [J]. FASEB J, 2006, 20: 782-784.
33. Jiang D, Liang J, Noble PW. Hyaluronan in tissue injury and repair [J]. Annu Rev Cell Dev Biol, 2007, 23: 435-461.
34. Bao XQ, Liu GT. Heat shock proteins: new target in cytoprotective and tumor therapy [J]. Acta Pharm Sin, 2008, 43: 234-240.
35. Ganter MT, Ware LB, Howard M, et al. Extracellular heat shock protein 72 is a marker of the stress protein response in acute lung injury [J]. Am J Physiol Lung Cell Mol Physiol, 2006, 291: L354-361.
36. Rubartelli A, Lotze MT. Inside, outside, upside down: damage-associated molecular-pattern molecules (DAMPs) and redox [J]. Trends Immunol, 2007, 28: 429-436.
37. Hamada N, Maeyama T, Kawaguchi T, et al. The role of high mobility group box1 in pulmonary fibrosis [J]. Am J Respir Cell Mol Biol, 2008, 39: 440-447.